Texas Woman’s University fashion students partnered with experts at Scottish Rite for Children to create clothes for children being treated for scoliosis. The school’s Mass Production Techniques class designed and created 16 fashionable yet functional outfits that take into account those working with medical devices like Halo traction for their treatment. On December 8, the students presented their colorful styles, which included wide necklines and fasteners in non-traditional locations.
Texas Radiology Associates named Mark Kalmar as the organization’s new CEO. Kalmar has more than 20 years of working with independent radiology groups and has excelled in physician recruitment, market expansion, and revenue enhancement. He most recently served as the chief administrative officer at Pacific Imaging Consultants in Oregon. Texas Radiology Associates employs 150 radiologists across the region.
The FDA has approved a kidney cancer drug that came out of scientific discoveries at UT Southwestern Medical Center. Peloton Therapeutics, which spun out of UTSW before being acquired by drug giant Merck, developed belzutifan, which is being marketed at Weligreg and is approved for anyone with metastatic clear cell renal cell carcinoma. The median survival rate for those with the disease is about 13 months, and the 5-year survival rate is under 10 percent. It is the most common subtype of kidney cancer.
Dr. Paul Thornton of Cook Children’s Health Care System has received the Global Impact Award from the City of Forth Worth for his lifetime of work in hyperinsulinism, a rare genetic disease that can be devastating. Thornton is the medical director of Diabetes and Endocrinology at Cook Children’s, ad helped establish two hyperinsulinism centers in the United States in Philadelphia at at Cook Children’s. Patients travel across the county to receive care from Thornton and the centers.
Author
